Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of renal function in chronic kidney disease patients

Clinical and Experimental Nephrology

Volumn 17, Issue 4, 2013, Pages 525-531

  Hataya, Yuji ^a   Igarashi, Shuta ^a   Yamashita, Takafumi ^a   Komatsu, Yasato ^a  

^a KYOTO CITY HOSPITAL   (Japan)

Author keywords

Chronic kidney disease; Glomerular filtration rate; Hypothyroidism; Thyroid hormone

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

AGE; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESTIMATED GLOMERULUS FILTRATION RATE; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GLOMERULUS FILTRATION RATE; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; THYROID FUNCTION; THYROID HORMONE REPLACEMENT THERAPY;

ADULT; AGED; FEMALE; GLOMERULAR FILTRATION RATE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; THYROXINE;

EID: 84883302393     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0727-y     Document Type: Article

References (28)

1. Kaptein EM, Feinstein EI, Massry SG. Thyroid hormone metabolism in renal diseases. Contrib Nephrol. 1982;33:122-35.
2. Verhelst J, Berwaerts J, Marescau B, Abs R, Neels H, Mahler C, et al. Serum creatine, creatinine, and other guanidino compounds in patients with thyroid dysfunction. Metabolism. 1997;46:1063-7.
3. den Hollander JG, Wulkan RW, Mantel MJ, Berghout A. Correlation between severity of thyroid dysfunction and renal function. Clin Endocrinol (Oxf). 2005;62:423-7.
4. Asvold BO, Bjøro T, Vatten LJ. Association of thyroid function with estimated glomerular filtration rate in a population-based study: the HUNT study. Eur J Endocrinol. 2011;164:101-5.
5. Capasso G, De Tommaso G, Pica A, Anastasio P, Capasso J, Kinne R, et al. Effects of thyroid hormones on heart and kidney functions. Miner Electrolyte Metab. 1999;25:56-64.
6. Lo JC, Chertow GM, Go AS, Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005;67:1047-52.
7. Ramirez G, O'Neill W Jr, Jubiz W, Bloomer HA. Thyroid dysfunction in uremia: evidence for thyroid and hypophyseal abnormalities. Ann Intern Med. 1976;84:672-6.
8. Bando Y, Ushiogi Y, Okafuji K, Toya D, Tanaka N, Miura S. Non-autoimmune primary hypothyroidism in diabetic and non-diabetic chronic renal dysfunction. Exp Clin Endocrinol Diabetes. 2002;110:408-15.
9. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982-92.
10. Salomon MI, Di Scala V, Grishman E, Brener J, Churg J. Renal lesions in hypothyroidism: a study based on kidney biopsies. Metabolism. 1967;16:846-52.
11. Crowley WF Jr, Ridgway EC, Bough EW, Francis GS, Daniels GH, Kourides IA, et al. Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med. 1977;296:1-6.
12. Villabona C, Sahun M, Roca M, Mora J, Gómez N, Gómez JM, et al. Blood volumes and renal function in overt and subclinical primary hypothyroidism. Am J Med Sci. 1999;318:277-80.
13. Asmah BJ, Wan Nazaimoon WM, Norazmi K, Tan TT, Khalid BA. Plasma renin and aldosterone in thyroid diseases. Horm Metab Res. 1997;29:580-3.
14. Zimmerman RS, Gharib H, Zimmerman D, Heublein D, Burnett JC Jr. Atrial natriuretic peptide in hypothyroidism. J Clin Endocrinol Metab. 1987;64:353-5.
15. Zimmerman RS, Ryan J, Edwards BS, Klee G, Zimmerman D, Scott N, et al. Cardiorenal endocrine dynamics during volume expansion in hypothyroid dogs. Am J Physiol. 1988;255:R61-6.
16. Schmid C, Brändle M, Zwimpfer C, Zapf J, Wiesli P. Effect of thyroxine replacement on creatinine, insulin-like growth factor 1, acid-labile subunit, and vascular endothelial growth factor. Clin Chem. 2004;50:228-31.
17. Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev. 1996;17:45-63.
18. Wiederkehr MR, Kalogiros J, Krapf R. Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrol Dial Transpl. 2004;19:1190-7.
19. Sanai T, Inoue T, Okamura K, Sato K, Yamamoto K, Abe T, et al. Reversible primary hypothyroidism in Japanese patients undergoing maintenance hemodialysis. Clin Nephrol. 2008;69:107-13.
20. Locatelli F, Pozzoni P, Tentori F, Del Vecchio L. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transpl. 2003;18(Suppl 7):vii2-9.
21. Kazory A, Ross EA. Anemia: the point of convergence or divergence for kidney disease and heart failure. J Am Coll Cardiol. 2009;53:639-47.
22. Levin A, Li YC. Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Kidney Int. 2005;68:1973-81.
23. Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol. 2009;20:1453-64.
24. Kahaly GJ. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid. 2000;10:665-79.
25. Vanhaelst L, Neve P, Chailly P, Bastenie PA. Coronary-artery disease in hypothyroidism. Observations in clinical myxoedema. Lancet. 1967;2:800-2.
26. Lekakis J, Papamichael C, Alevizaki M, Piperingos G, Marafelia P, Mantzos J, et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid. 1997;7:411-4.
27. Allon M, Harrow A, Pasque CB, Rodriguez M. Renal sodium and water handling in hypothyroid patients: the role of renal insufficiency. J Am Soc Nephrol. 1990;1:205-10.
28. Karanikas G, Schütz M, Szabo M, Becherer A, Wiesner K, Dudczak R, et al. Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy. Am J Nephrol. 2004;24:41-5.